BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 16713561)

  • 1. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
    Massoumi R; Chmielarska K; Hennecke K; Pfeifer A; Fässler R
    Cell; 2006 May; 125(4):665-77. PubMed ID: 16713561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of CYLD might be associated with development of salivary gland tumors.
    Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
    Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis.
    Budunova IV; Perez P; Vaden VR; Spiegelman VS; Slaga TJ; Jorcano JL
    Oncogene; 1999 Dec; 18(52):7423-31. PubMed ID: 10602501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
    Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
    Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control.
    Massoumi R; Paus R
    Bioessays; 2007 Dec; 29(12):1203-14. PubMed ID: 18008375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases.
    Ahn KS; Gong X; Sethi G; Chaturvedi MM; Jaiswal AK; Aggarwal BB
    Cancer Res; 2007 Oct; 67(20):10004-11. PubMed ID: 17942934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
    Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
    J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors.
    Fukuda M; Fukuda F; Horiuchi Y; Oku Y; Suzuki S; Kusama K; Sakashita H
    In Vivo; 2006; 20(4):467-72. PubMed ID: 16900776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
    Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.
    Qiao W; Li AG; Owens P; Xu X; Wang XJ; Deng CX
    Oncogene; 2006 Jan; 25(2):207-17. PubMed ID: 16170355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
    Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
    BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYLD in ubiquitin signaling and tumor pathogenesis.
    Ikeda F; Dikic I
    Cell; 2006 May; 125(4):643-5. PubMed ID: 16713556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutated cylindromatosis gene affects the functional state of dendritic cells.
    Bros M; Dexheimer N; Besche V; Masri J; Trojandt S; Hövelmeyer N; Reissig S; Massoumi R; Grabbe S; Waisman A; Reske-Kunz AB
    Eur J Immunol; 2010 Oct; 40(10):2848-57. PubMed ID: 20836156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
    Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
    J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cis-9,trans-11-conjugated linoleic acid down-regulates phorbol ester-induced NF-kappaB activation and subsequent COX-2 expression in hairless mouse skin by targeting IkappaB kinase and PI3K-Akt.
    Hwang DM; Kundu JK; Shin JW; Lee JC; Lee HJ; Surh YJ
    Carcinogenesis; 2007 Feb; 28(2):363-71. PubMed ID: 16950795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
    Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
    Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.